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CASE REPORT
Large pituitary incidentaloma in a patient with
sarcoidosis
Leena Jalota, MD*, Ana Abaroa-Salvatierra, MD and Richard Alweis, MD
Department of Internal Medicine, The Reading Health System, West Reading, PA, USA
A 60 year old male with a medical history of pulmonary sarcoidosis and chronic low testosterone presented to
his allergist for excessive lacrimation. Computed tomography (CT) scan of sinuses ordered for possible
blocked nasolacrimal duct revealed an abnormal expansion of the sella turcica. Magnetic resonance imaging
suggested a homogeneously enhancing 4 cm soft tissue mass enveloping the internal carotid and abutting the
optic nerves. Since the patient indicated no symptoms, it was felt to be consistent with a pituitary
incidentaloma. Laboratory investigation showed only minimally elevated prolactin. Visual field testing at the
office was normal but computed campimetry was suggestive of few minimally depressed points in the supra-
temporal quadrant on the right. Even with high suspicion of neurosarcoidosis, the patient had a surgical
indication so he underwent transsphenoidal excision of the mass with no complications. Pathology was
consistent with a null-cell pituitary adenoma.
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R
eady availability of computed tomography (CT)
scan and magnetic resonance imaging (MRI) has
led to increased detection of asymptomatic pitui-
tary adenomas, that is, ‘incidentalomas’, the prevalence
of which is estimated at 3.720% (1). Pituitary incidenta-
lomas are classified on the basis of size and hormonal
activity.Ofthenon-cystic-appearingincidentalomas,nearly
all arepituitary adenomas. As theyarenot associatedwith
hormonal hyper-secretion, they are often undiagnosed until
they grow enough to compress adjacent anatomical struc-
tures and thereby causevisual disturbances and/or impaired
pituitary function. Most clinically non-functional pituitary
adenomas are gonadotropic in origin, as determined by
immunocytochemical testing.
Although most pituitary incidentalomas can be safely
monitored until early signs appear, the differential diag-
nosis should consider other entities in patients with
pertinent medical history, for example, neurosarcoidosis
in this case. Neurosarcoidosis occurs in less than 5% of
patients with systemic sarcoidosis. Isolated neurosarcoi-
dosis without systemic involvement is extremely rare (2).
Importantly, even with benign pathology, large tumors
carry the riskof complications, such as pituitary apoplexy
secondary to acute intratumoral hemorrhage, or acute
visual loss.Wedescribethecaseofapatientwitha medical
history of sarcoidosis without any systemic involvement
that was found to have a pituitary mass.
Case
A 60-year-old male with a medical history of stage I
sarcoidosis and chronic hypergonadotropic hypogonad-
ism, with a history of prostate cancer treated with radio-
therapy and chemotherapy 10 years prior, self-referred to
his allergist for dry eyes with excessive lacrimation. He
denied visual disturbances, headache, nausea, vomiting,
weakness, weight changes, gynecomastia, sexual dysfunc-
tion, sweating, palpitations, heat or cold intolerance,
or dry skin. Vitals signs were normal. Fiberoptic nasal
endoscopic examination of nasal mucosa, septum, and
turbinates was without lesions or masses but did indicate
a deviated nasal septum to the right and nasal polyps on
the left. There was no thyromegaly. Weber, Rinne, and
hearing tests were all normal and the rest of the physical
examination was unremarkable. With suspicion for a
blocked nasolacrimal duct, a CT scan of the head and
sinuses was ordered, which showed an enlarged sella
turcica. MRI suggested a homogeneously enhancing 4
cm soft tissue mass centered in the sella turcica, extending
into both the left and right cavernous sinuses, encasing
50% of the left cavernous internal carotid artery and
displacing the optic chiasm (Fig. 1). Thyroid-stimulating
hormone (TSH), free t4, t3, GH, IGF-1, and 24-hour
urine cortisol levels were normal. The prolactin was min-
imally elevated (24.4 ng/mL, normal 2.6413.13 ng/ml).
Free testosterone and total testosterone were low (1.7 and
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luteinizing hormone (LH) 20.2 (1.812.0 mIU/L) and
normal follicular stimulating hormone (FSH) 4.65 (1.5
12.4 mIU/ml) (Table 1).
Ophthalmological evaluation revealed stable visual
acuity at 20/25 in the right eye and 20/20 in the left
eye. Non-dilated examination revealed no evidence of
ocular involvement from sarcoidosis. There was no affer-
ent pupillary defect or red desaturation. Color vision
(Ishihara plates) was normal, brisk, and equal. No optic
disc edema or pallor was noted. Confrontationvisual field
(VF) examination was reported normal at the office;
however, VF testing by computer-assisted campimetry
was reported as normal in the left eye and with few
minimally depressed points in the supra-temporal quad-
rant of the right eye. The patient underwent combined
transseptal transsphenoidal approach with resection of
the pituitary neoplasm (Fig. 2). Pathology returned
consistent with a null-cell adenoma.
Discussion
Endocrine incidentalomas are very common diagnoses in
primary care. Usually, they are discovered during imaging
studies performed for other non-endocrinological reasons
and are found in the thyroid, adrenal, and pituitary
glands. Pituitary incidentalomas are generally defined as
asymptomatic lesions of the pituitary gland and may
include pituitary adenomas or other sellar lesions. They
are classified based on size and hormonal secretion, that
is, microadenomas if they are B10 mm and macroade-
nomas if they are  10 mm in size.
The prevalence of pituitary incidentalomas has been
reported between 3.7 and 20% discovered on neuroima-
ging (MRI, CTscan) or autopsy (3, 4). However, pituitary
lesions  10 mm in diameter have been described only
between 0.16 and 0.3% on subjects who underwent CT
scan or MRI for unrelated reasons (5, 6). Independent of
size, hormonal hypersecretion can occur with any inci-
dentaloma (1 in 1,000 cases), but hyposecretion is usually
the result of a macroadenoma (7).
In various surgical series, prolactinomas and non-
secreting tumors each comprise approximately 3040%
of all tumors (8). Non-functioning pituitary adenomas
(NFPAs) are a heterogeneous group of tumors that
include null-cell adenomas, oncocytomas, gonadotropin-
secreting adenomas, adrenocorticotropin, growth hor-
mone, prolactin (PRL), and thyrotropin (TSH) adenomas.
Theirannualincidenceis45casesper millionpeoplewith
an estimated worldwide prevalence of 5060 cases per
million people (9). Asymptomatic incidentalomas are
independently associated with better outcomes (10).
The majority of pituitary adenomas are benign masses
that remain clinically silent and are associated with
minimal morbidity and mortality. However all the diag-
nostic possibilities should be considered because hormo-
nal hypersecretion and lesions that can enlarge and impair
pituitary hormone production or compress the optic
chiasm should be treated and corrected early.
The differential diagnosis of sellar incidentalomas is
broadandseveraltypesoflesionmaybefoundinthesellar
area that may mimic a pituitary adenoma. Such lesions
include aneurysm of the internal carotid artery, cranio-
pharyngiomas, meningiomas of the tuberculum sellae,
Fig. 1. Initial MRI sagittal view showing the pituitary mass
(dotted line). Homogeneously enhancing 4 cm soft tissue
mass centered in the sella turcica extending into both the left
and right cavernous sinus as well as abutting and displacing
the optic chiasm.
Table 1. Showing pre-op and post-op laboratory values
ACTH
(pg/ml)
Cortisol AM
(mg/dl)
TSH
(uIU/ml)
Free T4
(ng/dl)
LH
(mIU/ml)
FSH
(mIU/ml)
Total
testosterone
(ng/dl)
Free
testosterone
(ng/dl)
Prolactin
(ng/ml)
Reference range 650 8.722.4 0.44.5 0.581.64 1.248.62 1.2719.2 240950 930 218
Pre-op 38 13.4 4.3 1.6 20.2 4.65 58 1.7 24.4
Post-op 35 15 5.8 0.8 2.1 4.8 58 2.5 6.5
ACTH: adrenocorticotropic hormone; TSH: thyroid stimulating hormone; LH: luteinizing hormone; FSH: follicular stimulating hormone;
Pre-op: pre-operative; Post-op: post-operative.
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nomas, pars intermedia and Rathke cleft cysts, hamarto-
mas, metastases, sarcoidosis, and eosinophilic granulomas.
All of these have different clinical and imaging char-
acteristics that can guide the diagnosis, including patient
age, other simultaneous symptoms, previous history, and
rate of progression. However, the final diagnosis is only
established with tissue pathology.
Once a pituitary incidentaloma is discovered, there are
three features that should be addressed: functionality
(excess of any pituitary hormone), hypopituitarism, and
VF impairment(related to size of the adenoma and mass
effect). The most frequent deficit is hypogonadotropic
hypogonadism (30%) without hyperprolactinemia (1).
Our patient had a previous history of pulmonary
sarcoidosis, so the initial concern was for neurosarcoido-
sis. However, almost all cases (91%) of neurosarcoidosis
are diagnosed with neurologic symptoms or clinical hor-
monal deficits (11), neither of which were present in
our patient. In fact, we found a previous diagnosis of
hypogonadism that was not previously addressed, but
finally corresponded to a hypergonadotropic hypogonad-
ism without pituitary origin, commonly called andropause.
If the deficit was pituitary in origin, it would present with
low testosterone and low LH and FSH. Gonadotroph cell
adenomas are the most common histological subtype,
accounting for approximately 80% of non-functioning
pituitary adenomas; however, the secretion of these
tumors are usually non-functional subunits of FSH and
LH without any function and in rare caseswhere the FSH
production is functional, it would cause hypergonadism
which our patient did not have (12).
Our patient also had inactive pulmonary sarcoidosis at
the time of diagnosis and negative ophthalmologic evalua-
tion for sarcoidosis. The MRI findings in our patient was
consistent with pituitary adenoma with in-homogenously
expanding pituitary mass with asymmetrical suprasellar
extension and contralateral deviation of stalk, that are
usually not present in neurosarcoidosis or lymphocytic
hypophysitis (Fig. 1) (13).
Our patient presented with bilateral hyper lacrimation
as the main symptom. However, the innervation of lac-
rimal reflex is compound of afferent components of the
trigeminal andfacial nerve. Onlybilateral VII disease asin
Bell’spalsy will causebilateral symptoms,while trigeminal
diseasewillcausehypolacrimation.TheafferentVIInerve
branch related to the lacrimation track does not have
anatomic correlation with pituitaryor the cavernous sinus
so there was no possible correlation with the presenting
symptoms and pituitary finding (14).
Given the size of the tumor and the absence of VF
deficits, despite the displacement of the optic chiasm,
we concluded that this tumor likely had a slow growth
pattern that usually corresponds to non-functioning
macroadenoma.
Because the mass was displacing the optic nerves,
the decision was made to treat surgically and re-evaluate
according to pathological findings. He was found to have
a macroadenoma with null-cell pathologic features after
immune-histochemical stains. Post-operative MRI showed
a 7.6 mm residual mass wrapped around the Internal
Carotid Artery, which is being followed with serial MRIs.
A recent study indicated that post-operative residual
tumorwasdetected in8.9% ofpatientswithasymptomatic
incidentalomas, as compared with 31.2% of patients with
symptomatic incidentalomas and multivariate analysis
confirmed that having an asymptomatic incidentaloma
was independently associated with a better outcome (10).
However, this study did not differentiate between asymp-
tomatic incidentalomas in macro or microadenomas and
we believe that, even without symptoms, the size of the
tumor would change the final prognosis.
The 5-year recurrence-free survival in patients with
incidentaloma has been reported as 86.8% (8); however,
early diagnosis and comorbidities assessment remains
the key to avoid not only mortality but also morbidity,
as visual impairment and hypopituitarism are usually
irreversible in patients with slow tumor enlargement.
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